Top Health Tech Companies in Kolkata (14)
Co-founded by Harsimarbir (Harsh) Singh, Dr. Vaibhav Kapoor, and Dr. Garima Sawhney in August 2018, Pristyn Care (pristyncare.com) is a leader in Secondary Care Surgeries. The company has a team of 400+ expert surgeons, performing advanced surgeries for over 50+ diseases using the latest advanced medical technology such as Laser, Laparoscopy, Microdebriders, Lasik, etc. across 800+ Surgical Centres. It is...
Problem we are solving Over 450 rural residents in India are served by only 30 per cent of the country’s combined medical force. Recognising the gap, iKure is skilling community members to deliver last mile health care in remote rural communities. Leveraging technology, empowering community workers and implementing behaviour change programme, iKure’s unique healthcare model is creating healthy communities in rural...
About Us GCC Biotech Pvt. Ltd. founded in year 2006, is one of the pioneer biotech research based company in eastern part of India. Since its inception, it has facilitated many researchers, scientists and scholars from various research institutes with its products and services. Within a decade, the company has developed a multi-functional state-of-the-art infrastructure with DSIR recognition and ISO 9001:2008 and...
Pursuit Software helps clients leverage Information Technology to solve a wide array of business problems. We have over a decade of experience providing Information Technology (IT) services to leading companies in the United States and abroad. We have strong expertise in the following IT areas: Industry-Specific Solutions At Pursuit, we are always focused on solving business challenges, specifically in...
Profound Change Requires Boldness. Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years. The combination of new technologies and your expertise enables amazing things to happen. Teams from J&J’s consumer business are creating digital tools to help people track the...
Johnson & Johnson's Top Stability & Growth Strengths
Strong Revenue Growth: Companywide sales are described as increasing year over year, with momentum exiting 2025 and guidance calling for continued expansion into 2026.
Innovation-Driven Growth: Growth is attributed to innovative medicines and new product submissions, with oncology and immunology performance highlighted as key contributors.
Diversified Revenue Streams: The business is positioned around two large segments—Innovative Medicine and MedTech—creating a broader platform that helps offset declines in specific products.
A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how...
GSK's Top Stability & Growth Strengths
Strong Market Position & Advantage: GSK is positioned as a top-tier global biopharmaceutical company by revenue while showing category leadership in vaccines and HIV, anchored by franchises such as Shingrix and ViiV’s portfolio. Its consistent top-10/12 standing and segment leadership in vaccines, respiratory, and HIV support a stable competitive footing.
Resilient & Sustainable Growth: Revenue and earnings momentum are supported by broad-based growth across Specialty Medicines and continued contributions from Vaccines, alongside reaffirmed multi-year sales ambitions. Guidance for continued turnover and profit expansion indicates an expectation of ongoing, steadier growth rather than a one-off spike.
Healthy Cash Flow: Operating cash generation is described as strong and is being used to fund R&D investment and shareholder returns such as dividends and buybacks. This cash profile supports resilience through investment cycles and potential volatility in specific product areas.
Cozeva is building the operating system for value-based care. Our solutions enable real-time collaboration and drive measurable improvements in quality, equity, and cost. Learn more about how our latest products help payers and providers align around shared goals on a unified platform by visiting our website.
RAD365 is an Healthcare service provider delivering Teleradiology solutions, Knowledge Processing & Data Analytics solutions, Software solutions to the healthcare industry. Established in the year 2007, RAD365 is continuously helping healthcare organizations to operate effectively in a technology-driven environment. RAD365 is committed towards solving the real-world needs of the healthcare industry by developing strategic solutions. Our technological capabilities, consistent quality...
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.
Abbott's Top Stability & Growth Strengths
Strong Revenue Growth: Q2 2026 sales increased 13% reported (4.8% comparable), and management reaffirmed 6.5%–7.5% comparable sales growth while lifting full‑year EPS guidance. Multi‑segment contribution from Medical Devices and Diagnostics underpins a mid‑single‑digit organic growth trajectory.
Strong Market Position & Advantage: Leadership across CGM (FreeStyle Libre), structural heart TEER (MitraClip/TriClip), and core lab diagnostics supports top‑tier scale in medtech. The March 23, 2026 addition of Exact Sciences’ oncology screening and diagnostics further strengthens competitive positioning.
Diversified Revenue Streams: A broad mix across Devices, Diagnostics, Nutrition, and Established Pharmaceuticals reduces single‑category risk, with recurring models like Alinity’s instrument‑reagent base driving stickiness. Expansion into oncology diagnostics post‑acquisition adds another distinct growth engine.
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and...
Sanofi's Top Stability & Growth Strengths
Strong Revenue Growth: Sales growth is described as strong, with 2025 net sales up at constant exchange rates and Q4 showing further acceleration, indicating momentum into 2026.
Profitability: Earnings expansion is described as outpacing sales growth in 2025, and 2026 guidance indicates continued profitable expansion with EPS growing slightly faster than sales.
Product Line Growth: Newer launches are scaling rapidly, with notable growth in recent pharma launches and contributions from products beyond the flagship franchise, helping broaden growth drivers.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with...
Roche's Top Stability & Growth Strengths
Strong Market Position & Advantage: Roche is the global leader in in‑vitro diagnostics and remains a top‑tier biopharma with a significant oncology footprint. The dual Pharmaceuticals–Diagnostics model is a strategic differentiator at scale.
Strong Revenue Growth: Group sales rose 7% at constant exchange rates in 2025 and 6% at CER in Q1 2026, with both divisions contributing. Guidance for 2026 indicates continued mid–single‑digit CER growth.
Profitability: Profitability improved in 2025 alongside sales, with higher IFRS net income and core EPS growth. Management pointed to capacity to keep investing while rewarding shareholders.
Do the work of your life to help the lives of others. As a leading health technology company, it is our purpose to improve people’s health and well-being through meaningful innovation. Our goal is to improve 2.5 billion lives per year by 2030. We also strive to be the best place to work for people who share our passion, by promoting...
Philips's Top Stability & Growth Strengths
Strong Market Position & Advantage: Philips is positioned as a leader across multiple health-technology categories, with cited top standings in interventional systems, PACS, monitoring, and a large installed base that supports ongoing competitiveness.
Profitability: Margins are described as improving, with adjusted EBITA expanding through 2025 and management targeting further margin improvement into the mid-teens by 2028.
Innovation-Driven Growth: Innovation capacity is reinforced through repeated recognition as a top global innovator, sustained R&D intensity, and an innovation roadmap expected to contribute meaningfully to growth and margin improvement.
Innovodigm is developing a microneedle-based platform technology for effective, transdermal vaccine and biologics delivery. Our first product Theroptach is a thermostable painless vaccine delivery patch. This product will make vaccines more accessible to the remotest corners where vaccines cannot reach due to lack of proper infrastructure and trained healthcare professionals. Theroptach will completely eliminate the problem of vaccine wastage due to...
Every day, millions of patients, caregivers and providers around the world rely on Baxter’s leading portfolio of diagnostic, critical care, nutrition, kidney care, hospital and surgical products and solutions. For 90 years, we’ve been making an impact at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, therapies and...
Baxter International Inc.'s Top Stability & Growth Strengths
Strong Market Position & Advantage: Baxter is a leader in U.S. IV solutions and a top contender in connected-care hospital beds and surgical hemostats, underscoring durable share in core hospital categories. This positioning supports resilience despite category- and region-specific competition.
Product Line Growth: Ongoing updates to infusion technologies and continued launches in injectables and advanced surgery indicate a healthy product refresh cadence. FDA clearances and connected-care enhancements help sustain installed-base momentum.
Future-Ready Strategy: Portfolio reshaping (Kidney Care divestiture) and new leadership focused on execution and continuous improvement signal a sharpened hospital-centric strategy. Deleveraging and supply-chain initiatives aim to improve stability and long-term growth capacity.
